NCT02892890View on ClinicalTrials.gov

Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 19, 2016

Primary Completion Date

January 29, 2018

Study Completion Date

January 9, 2019

Conditions
Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Interventions
PROCEDURE

Muscle Magnetic Resonance Imaging (RMI) evaluation

DEVICE

MRI

Trial Locations (1)

13005

APHM, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT02892890 - Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin | Biotech Hunter | Biotech Hunter